Hypofractionated stereotactic radiotherapy (hfSRT) after tumour resection of a single brain metastasis: report of a single-centre individualized treatment approach
Journal of Cancer Research & Clinical Oncology, 05/10/2012Steinmann D et al.
Postoperative hypofractionated stereotactic radiotherapy (hfSRT) appears to be a feasible treatment option in patients with a single newly diagnosed brain metastasis. Replacing the standard postoperative whole–brain radiotherapy necessitates compliant patients and regular MRI follow–up analysis.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.